91茄子

Dr. Bolesta is a tenured Professor of Pharmacy Practice at the Nesbitt School of Pharmacy at 91茄子. He has over 20 years of experience in acute care pharmacy practice in critical care and internal medicine. He has a critical care clinical practice associated with his academic appointment at Commonwealth Health鈥檚 Wilkes-Barre General Hospital.

Dr. Bolesta completed a PGY 1 residency at the University of Arizona Medical Center and a PGY 2 critical care residency at the University of Kentucky Chandler Medical Center. He is a Board Certified Critical Care Pharmacist and is a Fellow of the American College of Critical Care Medicine and the American College of Clinical Pharmacy.

Dr. Bolesta is a former Chair of the Society of Critical Care Medicine鈥檚 Research Section and the American College of Clinical Pharmacy鈥檚 Critical Care Practice and Research Network. His research interests include iatrogenic withdrawal and cardiovascular science, specifically the prevalence, assessment, and prevention of iatrogenic withdrawal in critically ill patients and postoperative atrial fibrillation in cardiac surgery patients.

A full, up-to-date list of Dr. Bolesta's publications can be found on his Google Scholars page below.

• Dr. Bolesta's CV (.pdf)

• 91茄子 Nesbitt School of Pharmacy Fellowship Program
  • 2024 鈥� 2025 Nesbitt School of Pharmacy Wilkes-Barre, PA
• American Association of Colleges of Pharmacy Mid-Career Recharge Program
  • 2023 鈥� 2024 American Association of Colleges of Pharmacy Arlington, VA
• American College of Clinical Pharmacy Professional Leadership Development Program
  • 2022 鈥� 2023 American College of Clinical Pharmacy Lenexa, KS
• Precision Medicine Conference
  • University of Florida College of Pharmacy
  • March 2016 University of Florida Orlando, FL
• Graduate Summer Institute of Epidemiology and Biostatistics
  • Bloomberg School of Public Health
  • July 2015 The Johns Hopkins University Baltimore, MD
• The SHARE Approach: Essential Steps of Shared Decision Making
  • Funded by Agency for Healthcare Research and Quality (AHRQ)
  • May 2015 Pennsylvania Medical Society Harrisburg, PA
• Focused Investigator Training (FIT) Program
  • July 2014 American College of Clinical Pharmacy Research Institute Athens, GA
• Team Strategies to Enhance Performance and Patient Safety (STEPPS) Master Training
  • Funded by Agency for Healthcare Research and Quality (AHRQ)
  • August 2013 North Shore Long Island Jewish Health System New Hyde Park, NY
• Critical Care Specialty Residency
  • ASHP Accredited
  • July 2001 鈥� June 2002 University of Kentucky Medical Center Lexington, KY
• Pharmacy Practice Residency
  • ASHP Accredited
  • July 2000 鈥� June 2001 University of Arizona Medical Center Tucson, AZ
• Doctor of Pharmacy
  • Nesbitt School of Pharmacy 91茄子 Wilkes-Barre, PA
  • May 2000

• American College of Clinical Pharmacy, Critical Care Practice and Research Network, Publication of the Year: 2023
• Society of Critical Care Medicine Silver Snapshot Abstract Award: 2023
• Society of Critical Care Medicine Presidential Citation: 2009, 2012 鈥� 2015, 2017, 2019
• Fellow of the American College of Clinical Pharmacy: 2018
• Fellow of the American College of Critical Care Medicine: 2014
• American College of Clinical Pharmacy Volunteer Recognition: 2011, 2013

• PHA 599, Critical Care, 6 credit hours, 2 students per rotation block, Wilkes-Barre General Hospital, Wilkes-Barre, PA. Preceptor. June 2018 鈥� Present.
• PHA 510, Adult Internal Medicine Advanced Pharmacy Practice Experience, 6 credit hours, 2 students per rotation block, Wilkes-Barre General Hospital, Wilkes-Barre, PA. Preceptor. June 2021 鈥� Present.
• PHA 440, Introductory Pharmacy Practice Experience II, 1 credit hour, 2 students each week, Wilkes-Barre General Hospital, Wilkes-Barre, PA. Preceptor. Fall 2008 鈥� Present.
• PHA 310, Clinical Research and Design, 2 credits hours, 65 students, 91茄子, Nesbitt School of Pharmacy.
• PHA 423, Principles of Pharmacotherapeutics II, 2 credit hours, 65 students, Wilkes University, Nesbitt School of Pharmacy. Lecture. Lecturer.
• PHA 428, Pharmacotherapeutics V: Infectious Diseases, 4 credit hours, 65 students, 91茄子, Nesbitt School of Pharmacy, Lecture, Lecturer.
• PHA 521. Pharmacotherapeutics VII: Pulmonary Disorders, 2 credit hours, 65 students, 91茄子, Nesbitt School of Pharmacy
• PHA 523, Pharmacotherapeutics VIII: Cardiovascular Disorders, 4 credit hours, 65 students, 91茄子, Nesbitt School of Pharmacy
• PHA 525, Pharmacotherapeutics IX: Pharmacotherapeutics of Renal Disorders, 2 credit hours, 65 students, 91茄子, Nesbitt School of Pharmacy.

• G茅linas C (PI), Bolesta S (Co-I). Iatrogenic Withdrawal Syndrome from opioid and sedation therapy in critically ill adults: Content validation of its symptomatology with experts. Submitted March 2023; The Louise and Alan Edwards Foundation, McGill University. Amount requested: $49,972 in direct costs. Submitted. Funding period: 08/01/2023-12/31/2024. Receiving agency/agent: McGill University. Funded for $50,000.
• Bolesta S. Assessing Current Analgesia and Sedation Weaning Practices in Adult Critically Ill Patients. Submitted August 2019; 91茄子 Provost Research and Scholarship Grant. Amount requested: $12,301 in direct costs. Submitted. Funding period: 01/01/2020-12/31/2022. Receiving agency/agent: 91茄子. Funded for $12,301.
• Bolesta S. Continued Faculty and Peer-To-Peer Mentored Research in Cardiovascular Science. Submitted March 2019; 91茄子. Amount requested: $7080 in direct costs. Submitted. Funding period: 06/01/2019-08/31/2019. Receiving agency/agent: Wilkes University. Funded for $6550.
• Bolesta S. Advancing the Cardiovascular Science of Vitamin C in Cardiac Surgery Patients. Submitted September 2018; Geisinger Cardiovascular Service Line Research Foundation Fund. Amount requested: $8848 in direct costs. Submitted. Funding period: 10/01/2018-05/31/2019. Receiving agency/agent: Geisinger. Funded.
• Bolesta S. Continued Faculty and Peer-To-Peer Mentored Research in Cardiovascular Science. Submitted March 2018; 91茄子. Amount requested: $7314 in direct costs. Submitted. Funding period: 06/01/2018-08/31/2018. Receiving agency/agent: Wilkes University. Funded for $6877.

Journal Articles

• Amer M, AlMubayedh H, Bolesta S, G茅linas C. Analgesia First in Critically Ill Adults: Current Practices and Future Directions. Crit Care Clin. Published online ahead of print; June 23, 2025.
• Rucci JM, Law AC, Bolesta S, Quinn EK, Garcia MA, Gajic O, Boman K, Yus S, Goodspeed VM, Kumar V, Kashyap R, Walkey AJ, From The Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator Group, Variation in Sedative and Analgesic Use During the COVID-19 Pandemic and Associated Outcomes, CHEST Critical Care (2024), doi: https://doi.org/10.1016/j.chstcc.2024.100047.
• Bolesta S, Burry L, Perreault MM, G茅linas C, Smith KE, Eadie R, Carini F, Saltarelli K, Mitchell J, Harpel J, Stewart R, Riker RR, Fraser GL, Erstad BL, on behalf of the ALERT-ICU study investigators. International Analgesia and Sedation Weaning and Withdrawal Practices in Critically Ill Adults: The AduLt iatrogEnic withdRawal sTudy in the ICU (ALERT-ICU). Crit Care Med. 2023 Nov 1;51(11):1502-1514. DOI: 10.1097/CCM.0000000000005951
• Eadie R, McKenzie CA, Hadfield D, Kalk NJ, Bolesta S, Dempster M, McAuley DF, Blackwood B. Opioid, sedative, preadmission medication and iatrogenic withdrawal risk in UK adult critically ill patients: a point prevalence study. Int J Clin Pharm. 2023 Oct;45(5):1167-1175. doi: 10.1007/s11096-023-01614-9.
• Ivey KA, Bolesta S. Impact of Pharmacist Monitoring of Serum Triglycerides for Critically Ill Patients Receiving Propofol. Journal of Pharmacy Practice. 2022;0(0). doi:10.1177/08971900221134646

Book Chapters

• Bolesta S. Specialized Topics in Cardiovascular Disease. In: Baker WL, Berei T, Bolesta S, et al., eds. ACCP/ASHP Cardiology Pharmacy Preparatory Review and Recertification Course, 2024 ed. Lenexa, KS: American College of Clinical Pharmacy, 2024:641-680.
• Bolesta S. Acute kidney injury. In: Schwinghammer TL, Koehler JM, Borchert JS, Slain D, Park SK, eds. Schwinghammer鈥檚 Pharmacotherapy Casebook: A Patient-Focused Approach. 12th ed. New York: McGraw-Hill, 2023. 54;155-156.
• Bolesta S. Pancreatitis. In: DiPiro JT, Yee GC, Haines ST, Nolin TD, Ellingrod V, Posey LM, eds. DiPiro鈥檚 Pharmacotherapy: A Pathophysiologic Approach. 12th ed. New York: McGraw-Hill, 2023. 57:575-590.
• Bolesta S. Specialized Topics in Cardiovascular Disease. In: Baker WL, Berei T, Bolesta S, et al., eds. ACCP/ASHP Cardiology Pharmacy Preparatory Review and Recertification Course, 2023 ed. Lenexa, KS: American College of Clinical Pharmacy, 2023:641-680.
• Schmidt K, Bolesta S. Supportive Management of Sepsis. In: Stover Hielscher KR ed. Infections in Critically Ill Patients. American College of Clinical Pharmacy Infectious Diseases Self-Assessment Program (IDSAP). Lenexa, KS: American College of Clinical Pharmacy, 2022:33-58. ISBN-13: 978-1-952291-60-9.

• Iatrogenic Withdrawal Syndrome in the ICU. 7th Annual Rutgers Critical Care Symposium 2024. Piscataway, NJ; March 15, 2024.
• AduLt iatrogEnic withdRawal sTudy in the ICU (ALERT-ICU) - Global Results. NIHR Southampton Biomedical Research Centre Science Forum. Virtual; January 27, 2023.
• Iatrogenic Withdrawal Syndrome and The AduLt iatrogEnic withdRawal sTudy in the ICU (ALERT-ICU). Maine Medical Center Critical Care Grand Rounds. Virtual; December 1, 2022.
• The Pains of Opioid and Sedative Use in the ICU. Presented as part of the SCCM Michigan Chapter Fall CE Program, 鈥淯pdated Prescribing of Analgosedation in the Critically Ill: A Review of Contemporary Evidence.鈥� Virtual; November 29, 2022.
• What Fluids Are on the Menu: Fluid Stewardship in Acute Care Settings. American Society of Health System Pharmacists Midyear Clinical Meeting. Virtual; December 7, 2021.
• Withdrawal in the Critically Ill: Causes, Control, and Circumvention. Pennsylvania Pharmacists Association Annual Conference. Harrisburg, PA; September 24, 2021.
• Epidemiology, Risks and Implications of Iatrogenic Withdrawal. American Society of Health System Pharmacists Midyear Clinical Meeting. Virtual; December 9, 2020.
• What we Know About Withdrawal in the ICU. Pennsylvania Society of Critical Care Medicine 24th Annual Challenges in Critical Care: A Multidisciplinary Approach. Hershey, PA; August 16, 2019.
• How We Cause Withdrawal. Society of Critical Care Medicine 48th Annual Critical Care Congress. San Diego, CA; February 19, 2019.
• Continuum of Care: Closing the Gap from the ICU to the Floor to Home. Society of Critical Care Medicine 47th Annual Critical Care Congress, Clinical Pharmacy and Pharmacology Section Pre-Congress Symposium. San Antonio, TX; February 24, 2018.